NLRP3 and inflammatory bowel disease: Studies in macrophages and mouse models of colitis have linked abnormal NLRP3 inflammasome activation with inflammatory bowel disease, including ulcerative colitis and Crohn’s disease (Cheng et al., 2015; Guo et al., 2015; Sun et al., 2015).